Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Erlotinib | 0.01 | uM | 10 | 1250.00 | 520.59 | 2951.67 | 2644.17 | 1.1155 | 1.0930 |
MDA-MB-231 | Erlotinib | 0.031623 | uM | 10 | 1250.00 | 520.59 | 2895.67 | 2644.17 | 1.0967 | 1.0801 |
MDA-MB-231 | Erlotinib | 0.1 | uM | 10 | 1250.00 | 520.59 | 2892.67 | 2644.17 | 1.0954 | 1.0792 |
MDA-MB-231 | Erlotinib | 0.31623 | uM | 10 | 1250.00 | 520.59 | 2822.00 | 2644.17 | 1.0662 | 1.0535 |
MDA-MB-231 | Erlotinib | 1 | uM | 10 | 1250.00 | 520.59 | 2734.67 | 2644.17 | 1.0357 | 1.0227 |
MDA-MB-231 | Erlotinib | 3.1623 | uM | 10 | 1250.00 | 520.59 | 2854.67 | 2644.17 | 1.0791 | 1.0637 |
MDA-MB-231 | Erlotinib | 10 | uM | 10 | 1250.00 | 520.59 | 2548.67 | 2644.17 | 0.9649 | 0.9697 |
MDA-MB-231 | Erlotinib | 19.9526 | uM | 10 | 1250.00 | 520.59 | 1886.00 | 2644.17 | 0.7126 | 0.7300 |
MDA-MB-231 | Lapatinib | 0.0016596 | uM | 10 | 1250.00 | 520.59 | 3027.00 | 2644.17 | 1.1454 | 1.1194 |
MDA-MB-231 | Lapatinib | 0.0033113 | uM | 10 | 1250.00 | 520.59 | 2840.67 | 2644.17 | 1.0746 | 1.0621 |
MDA-MB-231 | Lapatinib | 0.01 | uM | 10 | 1250.00 | 520.59 | 2662.33 | 2644.17 | 1.0056 | 1.0014 |
MDA-MB-231 | Lapatinib | 0.031623 | uM | 10 | 1250.00 | 520.59 | 2936.00 | 2644.17 | 1.1089 | 1.0884 |
MDA-MB-231 | Lapatinib | 0.1 | uM | 10 | 1250.00 | 520.59 | 2837.00 | 2644.17 | 1.0726 | 1.0604 |
MDA-MB-231 | Lapatinib | 0.31623 | uM | 10 | 1250.00 | 520.59 | 2903.67 | 2644.17 | 1.0994 | 1.0825 |
MDA-MB-231 | Lapatinib | 1 | uM | 10 | 1250.00 | 520.59 | 2966.33 | 2644.17 | 1.1216 | 1.0992 |
MDA-MB-231 | Lapatinib | 3.1623 | uM | 10 | 1250.00 | 520.59 | 3136.33 | 2644.17 | 1.1860 | 1.1505 |
MDA-MB-231 | Lapatinib | 10 | uM | 10 | 1250.00 | 520.59 | 2100.67 | 2644.17 | 0.7914 | 0.7977 |
MDA-MB-231 | Omipalisib | 0.0016596 | uM | 10 | 1250.00 | 520.59 | 2213.00 | 2316.17 | 0.9414 | 0.9095 |
MDA-MB-231 | Omipalisib | 0.0033113 | uM | 10 | 1250.00 | 520.59 | 2109.67 | 2316.17 | 0.8788 | 0.8124 |
MDA-MB-231 | Omipalisib | 0.01 | uM | 10 | 1250.00 | 520.59 | 1855.33 | 2316.17 | 0.7480 | 0.6241 |
MDA-MB-231 | Omipalisib | 0.031623 | uM | 10 | 1250.00 | 520.59 | 1482.33 | 2316.17 | 0.5914 | 0.4259 |
MDA-MB-231 | Omipalisib | 0.1 | uM | 10 | 1250.00 | 520.59 | 1126.00 | 2316.17 | 0.4543 | 0.2530 |
MDA-MB-231 | Omipalisib | 0.31623 | uM | 10 | 1250.00 | 520.59 | 901.33 | 2316.17 | 0.3862 | 0.1779 |
MDA-MB-231 | Omipalisib | 1 | uM | 10 | 1250.00 | 520.59 | 695.33 | 2316.17 | 0.3129 | 0.0633 |
MDA-MB-231 | Omipalisib | 3.1623 | uM | 10 | 1250.00 | 520.59 | 594.00 | 2316.17 | 0.2831 | 0.0116 |